MAPK8IP1P2 and thyroid cancer: Liu et al. showed that the MAPK8IP1P2-mediated upregulation of NF2, RASSF1 and RASSF5 leads to the activation of the antitumorigenic Hippo signaling pathway in thyroid cancer cells.